Bridge Therapeutics Reports Progress Against Opioid Use Disorder
Darren Prince To Join Commercial Advisory Board NEW YORK, NEW YORK, UNITED STATES, August 29, 2022 /EINPresswire.com/ -- Bridge Therapeutics, a developmental stage pharmaceutical company, today reported continued progress towards Phase 3 FDA approval of …